Novartis AG is 152.9x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($293.70 B vs $1.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OCUL | NVS |
|---|---|---|
| Market cap | $1.92 B | $293.70 B |
| US-listed rank | #2135 | #46 |
| Revenue (latest FY) | $51.95M | - |
| Net income (latest FY) | -$265.94M | - |
| Net margin | -511.9% | - |
| SEC filings | 827 | 947 |
Novartis AG is 152.9x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($293.70 B vs $1.92 B).
Full pages: OCULAR THERAPEUTIX, INC and Novartis AG, or browse the full rankings.